Not another sclerofoam.
A totally new vein therapy!
The miracle how to get rid of any varicose veins in a few minutes.
Biovena is like nothing before.
An innovation in sclerofoam therapy that miraclessly rids people of their varicose veins.
What makes BioVena Biomatrix Sclerofoam Stand Out?
- Painlessly treat varicose veins without thermal ablation, surgery or other high risk medications.
- Biovena is a biologically based method making it a first in the field of varicose vein therapies.
- Easily distributed, Biovena effectively treats all pathological veins; whether superficial or deeper lying.
- The therapeutic applications are not limited by complex varicose veins. Postoperative recurrent varicose veins, varicoceles, abdominal varices, or even late stage varicose veins are perfect for Biovena.
Fast collapsing, blood-deactivated regular sclerofoam
Stable and active Biomatrix sclerofoam
A Totally New Invention
U.S. patent No. US11229601B2 granted 2022-01-25!
These patented methods allow immense numbers of people with healthy and beautiful legs.
A sophisticated laboratory mechanism turns low quantities of sclerosant agents into a fully biological injectable medical foam.
With over 30,000 treated cases, Biovena is a promising medical application in the treatment of varicose veins.
SEEING IS BELIEVING!
Have a look at some of our patients' results and see for yourself the difference we can make.
Pre
Post
Pre
Post
Pre
Post
Invest in the Future of Vein Therapy
Every other person is born with vein valve lesions. Half of them will develop a serious vein disease over their lifetime. Through Venartis more people can get the help and treatment they deserve.
Venartis has a primary focus on venous disease in collaboration with the world renowned Dr. Johann Christof Ragg, MD, founder of the Angioclinic Vein Center clinics in Europe. His 25 years of intensive research in vascular diseases has revolutionized the field of phlebology. Venartis continues his legacy and research.
Investors are welcomed to take part in the evolution of vein therapy, constantly progressing and pushing further away from surgical intervention. From a focus on minimally invasive intervention to prevention therapies, Venartis is the only company on the planet that offers strategies and products to conquer the multi-billion-dollar phlebology -markets.
Please use the contact form to submit a message and receive more specific information.
You are a Patient?
Are you visiting these pages because you or someone in your family is affected by vein disease? Are you interested in the best therapies? You've come to the right place. There is so much good news for you: conditions like varicose veins are preventable! Do you already have varicose veins, or even have had vein surgery? No problem. In any case, there is a painless perfect solution without surgery! All ugly veins will simply disappear. You can protect yourself and your whole family from developing venous insufficiency, leg swelling, pain, skin damage and the dangers of thrombosis!
Please use the contact form to ask us your questions!
No surgery
No compression stockings
Treatment time about 30 minutes
No anesthesia
Painless
No cuts
No bruises
No hospital stay
Immediately fit for work and social life
Regular sports possible immediately
Bathing possible immediately
Permanent result to feel good
No scars
Long-term result - no more varicose veins
No side effects
Individual treatment depending on the cause
Very good tolerability
Dermatologically tested
Our teams will be happy to help you!
The Venartis®Group is the world's leading force for innovation in venous medicine. Our teams are constantly working on improvements that every patient can feel. There is so much more Venartis® knowledge than we can present here - for patients, companies, scientists, and investors.
Please use our contact form to obtain more specific information!
BioVena
Chaltenbodenstrasse 16
CH - 8834 Schindellegi
Gem. Feusisberg (SZ)
Phone: +41 438 44 44 73
Email: info@biovena.ch
UID: CHE-277.924.035
Company Register No.: HR01-1005050246
CEO
Karolina Pahlitzsch
MSL Manager
Margaryta Dittert
